AdventHealth Leads the Nation in STAR Trial Enrollment

AdventHealth Research Institute (AHRI) is proud to be the highest enrolling site in the United States for the STAR trial—a groundbreaking study testing a potential new treatment for babies with hypoxic-ischemic encephalopathy (HIE), a serious condition caused by lack of oxygen at birth.

Doubling Expectations

Thanks to the leadership of Dr. Leslie Pineda, who became a research investigator with AHRI just last year, our team has already doubled the sponsor’s enrollment goal. While the sponsor hoped for 4 enrollments, AHRI has successfully enrolled 8 babies—more than any other site in the nation.

Around-the-Clock Commitment

Because STAR is a 24-hour trial, eligible newborns can be admitted at any time, day or night. Dr. Pineda and her team have adjusted schedules and extended support across campuses to ensure every qualifying baby can be a part of this research.

To learn more about this study please click below.